2nd Quarter - Report
THORN RUN PARTNERS for BIOGEN
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
CMS proposed rule potential and potential legislation that includes provisions that would alter payment policies under Medicare Part B for drugs and biologics. Issues dealing with value-based contracts. Issues pertaining to Medicare Part D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BEAU SCHUYLER | Legislative Director - Cong. Tanner, Legislative Director - Cong. McIntyre |
Medical/Disease Research/Clinical Labs MED
Issues dealing with newborn screening. Issues dealing with Alzheimer's treatments.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BEAU SCHUYLER | Legislative Director - Cong. Tanner, Legislative Director - Cong, McIntyre |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.